| 2025-11-12 | -28.5% | news | Seeking Alpha | Sanara MedTech signals strategic shift with THP discontinuation and continued surgical growth focus |
| 2025-11-12 | -28.5% | earnings | Seeking Alpha | Sanara MedTech Inc. (SMTI) Q3 2025 Earnings Call Transcript |
| 2025-11-12 | -28.5% | earnings | Seeking Alpha | Sanara MedTech GAAP EPS of $0.09 beats by $0.30, revenue of $26.3M misses by $0.33M |
| 2025-11-12 | -28.5% | legal | SEC EDGAR | SMTI 8-K: 2.02 and (SEC Filing) |
| 2025-11-12 | -28.5% | earnings | Yahoo Finance | Sanara MedTech Inc (SMTI) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance |
| 2025-11-11 | -25.3% | earnings | Yahoo Finance | What To Expect From Sanara MedTech Inc (SMTI) Q3 2025 Earnings - Yahoo Finance |
| 2023-11-13 | +16.9% | legal | SEC EDGAR | SMTI 8-K: 2.02 and (SEC Filing) |
| 2025-03-25 | -16.0% | earnings | Seeking Alpha | Sanara MedTech targets pilot launch of Tissue Health Plus in Q2 2025 |
| 2025-03-25 | -16.0% | earnings | Seeking Alpha | Sanara MedTech Inc. (SMTI) Q4 2024 Earnings Call Transcript |
| 2025-03-25 | -16.0% | earnings | Seeking Alpha | Sanara MedTech GAAP EPS of -$0.18 misses by $0.06, revenue of $26.31M beats by $0.51M |
| 2025-03-25 | -16.0% | legal | SEC EDGAR | SMTI 8-K: 2.02 and (SEC Filing) |
| 2024-08-13 | +15.6% | earnings | Seeking Alpha | Sanara MedTech Inc. (SMTI) Q2 2024 Earnings Call Transcript |
| 2022-08-26 | +14.7% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Sanara MedTech (SMTI) - Zacks Investment Research |
| 2024-05-14 | +14.6% | earnings | Seeking Alpha | Sanara MedTech Inc. (SMTI) Q1 2024 Earnings Call Transcript |
| 2024-05-14 | +14.6% | earnings | Seeking Alpha | Sanara MedTech EPS of -$0.21, revenue of $18.5M misses by $0.7M |
| 2025-01-21 | +14.1% | earnings | Seeking Alpha | Sanara MedTech expects Q4 revenue in the range of $25.7M to $26.2M |
| 2025-01-21 | +14.1% | legal | SEC EDGAR | SMTI 8-K: 2.02 and (SEC Filing) |
| 2024-08-12 | +13.2% | earnings | Seeking Alpha | Sanara MedTech GAAP EPS of -$0.41 misses by $0.20, revenue of $20.2M beats by $1.1M |
| 2024-08-12 | +13.2% | legal | SEC EDGAR | SMTI 8-K: 2.02 and (SEC Filing) |
| 2022-11-15 | +13.1% | legal | SEC EDGAR | SMTI 8-K: 2.02 (SEC Filing) |
| 2025-05-14 | -12.6% | earnings | Seeking Alpha | Sanara MedTech outlines 26% revenue growth and targets expansion to over 1,450 facilities by year-end 2025 while launching THP pilot |
| 2025-05-14 | -12.6% | earnings | Seeking Alpha | Sanara MedTech Inc. (SMTI) Q1 2025 Earnings Call Transcript |
| 2025-05-14 | -12.6% | earnings | Seeking Alpha | Sanara MedTech GAAP EPS of -$0.41 beats by $0.10, revenue of $23.4M misses by $0.08M |
| 2025-05-14 | -12.6% | legal | SEC EDGAR | SMTI 8-K: 2.02 and (SEC Filing) |
| 2022-07-05 | +11.9% | legal | SEC EDGAR | SMTI 8-K: 1.01, 2.01, 3.02, 7.01 (SEC Filing) |
| 2023-08-14 | -11.9% | legal | SEC EDGAR | SMTI 8-K: 2.02 and (SEC Filing) |
| 2026-04-14 | +11.7% | news | GlobeNewswire | Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026 |
| 2026-04-14 | +11.7% | news | GlobeNewswire | Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026 - GlobeNewswire |
| 2026-04-14 | +11.7% | news | Stock Titan | Sanara MedTech sets May 12 webcast for first-quarter 2026 results - Stock Titan |
| 2026-03-24 | -11.1% | earnings | GuruFocus.com | Sanara MedTech Inc (SMTI) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... |
| 2026-03-24 | -11.1% | earnings | MarketBeat | Sanara MedTech Q4 Earnings Call Highlights |
| 2026-03-24 | -11.1% | earnings | Zacks | Sanara MedTech Inc. (SMTI) Q4 Earnings Miss Estimates |
| 2026-03-24 | -11.1% | earnings | GlobeNewswire | Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance |
| 2026-03-24 | -11.1% | earnings | Seeking Alpha | Sanara MedTech outlines 2026 net revenue guidance of $116M–$121M while expanding distributor network and product reach |
| 2026-03-24 | -11.1% | earnings | Seeking Alpha | Sanara MedTech Inc. (SMTI) Q4 2025 Earnings Call Transcript |
| 2026-03-24 | -11.1% | earnings | Seeking Alpha | Sanara MedTech GAAP EPS of -$0.19, revenue of $27.5M |
| 2026-03-24 | -11.1% | legal | SEC EDGAR | SMTI 8-K: 2.02 and (SEC Filing) |
| 2026-03-24 | -11.1% | earnings | Yahoo Finance | Sanara MedTech Inc. (SMTI) Q4 Earnings Miss Estimates - Yahoo Finance |
| 2026-03-24 | -11.1% | news | GlobeNewswire | Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and - GlobeNewswire |
| 2026-03-24 | -11.1% | earnings | Bayelsa Watch | Sanara MedTech Inc. (SMTI) Q4 and Full Year 2025 Earnings: Revenue Hits $103.1 Million With 19% Growth - Bayelsa Watch |
| 2025-01-22 | +11.0% | legal | SEC EDGAR | SMTI 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-01-22 | +11.0% | legal | SEC EDGAR | SMTI 8-K: 1.01, 7.01, 8.01 (SEC Filing) |
| 2025-08-13 | +10.3% | news | Seeking Alpha | Sanara MedTech outlines $5.5M–$6.5M THP investment target while advancing surgical segment growth |
| 2025-08-13 | +10.3% | earnings | Seeking Alpha | Sanara MedTech Inc. (SMTI) Q2 2025 Earnings Call Transcript |
| 2025-08-13 | +10.3% | earnings | Seeking Alpha | Sanara MedTech reports Q2 results |
| 2025-08-13 | +10.3% | legal | SEC EDGAR | SMTI 8-K: 2.02 and (SEC Filing) |
| 2025-08-13 | +10.3% | news | simplywall.st | Sanara MedTech Inc. (NASDAQ:SMTI) Doing What It Can To Lift Shares - simplywall.st |
| 2025-05-13 | -9.7% | earnings | GuruFocus | What To Expect From Sanara MedTech Inc (SMTI) Q1 2025 Earnings - GuruFocus |
| 2025-03-24 | -9.2% | earnings | GuruFocus | Earnings To Watch: Sanara MedTech Inc (SMTI) Reports Q4 2024 Res - GuruFocus |
| 2024-09-23 | -8.7% | legal | SEC EDGAR | SMTI 8-K: 5.02 and (SEC Filing) |
| 2024-04-18 | +8.0% | legal | SEC EDGAR | SMTI 8-K: 1.01, 1.02, 2.03, 7.01 (SEC Filing) |
| 2021-08-16 | -7.9% | legal | SEC EDGAR | SMTI 8-K: 2.02 and (SEC Filing) |
| 2024-05-22 | -7.6% | news | Seeking Alpha | Sanara MedTech files to sell 255,049 shares of common stock for holders |
| 2024-11-12 | +6.6% | earnings | Seeking Alpha | Sanara MedTech GAAP EPS of -$0.34 beats by $0.28, revenue of $21.7M beats by $1M |
| 2024-11-12 | +6.6% | legal | SEC EDGAR | SMTI 8-K: 2.02 and (SEC Filing) |
| 2024-11-12 | +6.6% | earnings | Stock Titan | Sanara MedTech Reports 35% Revenue Surge to $21.7M, Marks 12th Straight Record Quarter - Stock Titan |
| 2022-02-22 | +6.6% | legal | SEC EDGAR | SMTI 8-K: 2.02 and (SEC Filing) |
| 2023-08-02 | +5.6% | legal | SEC EDGAR | SMTI 8-K: 1.01, 2.01, 2.03, 3.02, 7.01 (SEC Filing) |
| 2022-07-15 | +5.5% | legal | SEC EDGAR | SMTI 8-K: 2.01 and (SEC Filing) |
| 2024-05-13 | -5.4% | earnings | Seeking Alpha | Sanara MedTech EPS of -$0.21 misses by $0.14, revenue of $18.5M in-line |
| 2024-05-13 | -5.4% | legal | SEC EDGAR | SMTI 8-K: 2.02, 5.02 (SEC Filing) |
| 2024-10-07 | +5.4% | legal | SEC EDGAR | SMTI 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-01-23 | -5.0% | earnings | Seeking Alpha | Sanara MedTech expects Q4 revenue between $27.2M and$27.7M |
| 2026-01-23 | -5.0% | legal | SEC EDGAR | SMTI 8-K: 2.02 and (SEC Filing) |
| 2021-06-04 | +4.9% | legal | SEC EDGAR | SMTI 8-K: 7.01, 8.01 (SEC Filing) |
| 2022-12-06 | +4.9% | legal | SEC EDGAR | SMTI 8-K: 5.02 and (SEC Filing) |
| 2023-05-15 | -4.7% | legal | SEC EDGAR | SMTI 8-K: 2.02 and (SEC Filing) |
| 2022-03-30 | +4.7% | legal | SEC EDGAR | SMTI 8-K: 2.02 and (SEC Filing) |
| 2024-11-13 | +4.6% | earnings | Seeking Alpha | Sanara MedTech Inc. (SMTI) Q3 2024 Earnings Call Transcript |
| 2021-12-28 | +4.3% | legal | SEC EDGAR | SMTI 8-K: 5.02, 7.01 (SEC Filing) |
| 2022-11-14 | +4.1% | legal | SEC EDGAR | SMTI 8-K: 2.02 and (SEC Filing) |
| 2026-04-23 | -4.1% | news | Insider Monkey | What Makes Sanara Medtech (SMTI) A Compelling Risk-Reward Opportunity? |
| 2026-04-23 | -4.1% | news | Insider Monkey | What Makes Sanara Medtech (SMTI) A Compelling Risk-Reward Opportunity? - Insider Monkey |
| 2022-04-29 | -3.9% | legal | SEC EDGAR | SMTI 8-K: 5.02 and (SEC Filing) |
| 2026-04-20 | -3.8% | news | Simply Wall St. | How The Sanara MedTech (SMTI) Story Is Shifting With New Targets And Growth Assumptions |
| 2026-04-20 | -3.8% | news | Cổng thông tin điện tử tỉnh Lào Cai | Sanara MedTech (SMTI) Stock Swing Trade (Bullish Sentiment) 2026-04-20 - Investment Community Signals - Cổng thông tin điện tử tỉnh Lào Cai |
| 2022-01-06 | -3.8% | legal | SEC EDGAR | SMTI 8-K: 5.02 (SEC Filing) |
| 2025-11-13 | +3.7% | earnings | simplywall.st | Sanara MedTech (SMTI) Is Down 23.5% After Q3 Loss and THP Exit – Has the Investment Case Shifted? - simplywall.st |
| 2026-04-07 | -3.7% | news | Cổng thông tin điện tử tỉnh Tây Ninh | Can Sanara MedTech (SMTI) Stock Rebound in 2026 | Price at $16.83, Down 2.09% - Social Buy Zones - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2025-09-01 | +3.6% | analyst | Yahoo Finance | Analysts Expect Breakeven For Sanara MedTech Inc. (NASDAQ:SMTI) Before Long - Yahoo Finance |
| 2022-04-04 | +3.5% | legal | SEC EDGAR | SMTI 8-K: 1.01, 3.02, 7.01 (SEC Filing) |
| 2024-05-30 | -3.5% | legal | SEC EDGAR | SMTI 8-K: 5.02 (SEC Filing) |
| 2022-05-16 | +3.3% | legal | SEC EDGAR | SMTI 8-K: 2.02 and (SEC Filing) |
| 2022-03-28 | -3.0% | legal | SEC EDGAR | SMTI 8-K: 1.02, 5.08and8.01 (SEC Filing) |
| 2023-02-24 | +2.9% | legal | SEC EDGAR | SMTI 8-K: 1.01 and (SEC Filing) |
| 2026-03-02 | +2.8% | news | Stock Titan | Sanara MedTech (NASDAQ: SMTI) furnishes 2026 outlook deck - Stock Titan |
| 2025-11-20 | +2.7% | legal | Business Wire | Securities Fraud Investigation Into Sanara MedTech Inc. (SMTI) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm - Business Wire |
| 2021-12-22 | -2.7% | legal | SEC EDGAR | SMTI 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-04-23 | +2.5% | earnings | Stock Titan | Sanara MedTech Earnings Preview: Medical Tech Leader Reveals Q1 2025 Results May 14 - Stock Titan |
| 2024-03-06 | -2.4% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2023-03-20 | -2.4% | legal | SEC EDGAR | SMTI 8-K: 2.02 and (SEC Filing) |
| 2026-03-23 | -2.3% | earnings | GuruFocus.com | What To Expect From Sanara MedTech Inc (SMTI) Q4 2025 Earnings |
| 2026-03-23 | -2.3% | executive | Stock Titan | Sanara MedTech (SMTI) CEO receives 25,430-share restricted stock grant vesting through 2029 - Stock Titan |
| 2026-03-23 | -2.3% | executive | Stock Titan | Sanara MedTech (SMTI) awards COO 13,956 restricted shares - Stock Titan |
| 2026-03-23 | -2.3% | news | Stock Titan | Sanara MedTech (SMTI) grants restricted stock to controller vesting through 2029 - Stock Titan |
| 2026-04-16 | +2.3% | executive | Stock Titan | Sanara MedTech (SMTI) COO reports tax withholding on vested restricted stock - Stock Titan |
| 2026-04-16 | +2.3% | analyst | Meyka | SMTI: Lake Street Initiates Buy Rating on Sanara MedTech - Meyka |
| 2026-04-08 | -2.3% | news | Cổng thông tin điện tử Tỉnh Sơn La | Is Sanara MedTech (SMTI) Stock suitable for dividend investors | Price at $17.14, Up 1.84% - Popular Picks - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-03-28 | +2.3% | news | UBND thành phố Hải Phòng | Is Sanara MedTech (SMTI) Stock in consolidation phase | Price at $16.65, Up 0.73% - Expert Momentum Signals - UBND thành phố Hải Phòng |
| 2024-09-11 | +2.2% | legal | SEC EDGAR | SMTI 8-K: 7.01, 8.01 (SEC Filing) |
| 2025-05-23 | -2.1% | legal | SEC EDGAR | SMTI 8-K: 5.02 (SEC Filing) |
| 2024-04-05 | -1.7% | legal | SEC EDGAR | SMTI 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-03-11 | -1.4% | news | GlobeNewswire | Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds |
| 2026-03-11 | -1.4% | news | GlobeNewswire | Sanara MedTech Inc. Announces Publication of Peer-Reviewed - GlobeNewswire |
| 2024-03-29 | -1.3% | earnings | TradingView | Sanara MedTech Inc. Revenue Breakdown – NASDAQ:SMTI - TradingView |
| 2021-07-19 | +1.3% | legal | SEC EDGAR | SMTI 8-K: 1.01, 3.02, 7.01 (SEC Filing) |
| 2024-03-25 | -1.3% | legal | SEC EDGAR | SMTI 8-K: 2.02 and (SEC Filing) |
| 2024-06-18 | -1.1% | legal | SEC EDGAR | SMTI 8-K: 5.02 and (SEC Filing) |
| 2024-02-22 | -1.0% | legal | SEC EDGAR | SMTI 8-K: 2.02 and (SEC Filing) |
| 2021-12-15 | +1.0% | legal | SEC EDGAR | SMTI 8-K: 5.02, 7.01 (SEC Filing) |
| 2022-04-08 | +1.0% | legal | SEC EDGAR | SMTI 8-K: 1.01, 2.01, 3.02, 7.01 (SEC Filing) |
| 2026-03-25 | +0.9% | earnings | Moby | Sanara MedTech Inc. Q4 2025 Earnings Call Summary |
| 2022-08-15 | +0.6% | legal | SEC EDGAR | SMTI 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-02-22 | -0.5% | legal | SEC EDGAR | SMTI 8-K: 2.02 and (SEC Filing) |
| 2025-06-09 | +0.4% | news | Seeking Alpha | Sanara MedTech: Pursuing Rapid Expansion While Debt Levels Climb |
| 2025-06-09 | +0.4% | news | Seeking Alpha | Sanara MedTech: Pursuing Rapid Expansion While Debt Levels Climb (NASDAQ:SMTI) - Seeking Alpha |
| 2025-09-04 | -0.4% | news | Seeking Alpha | Sanara MedTech: Growth Remains Strong As Debt Concerns Recede |
| 2025-09-04 | -0.4% | news | Seeking Alpha | Sanara MedTech: Growth Remains Strong As Debt Concerns Recede (NASDAQ:SMTI) - Seeking Alpha |
| 2025-04-04 | -0.3% | legal | SEC EDGAR | SMTI 8-K: 1.01, 2.01, 8.01 (SEC Filing) |
| 2025-09-02 | -0.2% | executive | Seeking Alpha | Sanara MedTech appoints new CEO |
| 2025-09-02 | -0.2% | legal | SEC EDGAR | SMTI 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-11-27 | +0.2% | earnings | Seeking Alpha | Sanara MedTech: Too Cheap And Better Positioned After Earlier Strategic Missteps |
| 2025-11-27 | +0.2% | earnings | Seeking Alpha | Sanara MedTech: Too Cheap And Better Positioned After Earlier Strategic Missteps (NASDAQ:SMTI) - Seeking Alpha |
| 2021-11-15 | -0.2% | legal | SEC EDGAR | SMTI 8-K: 2.02 and (SEC Filing) |
| 2021-08-06 | +0.1% | legal | SEC EDGAR | SMTI 8-K: 5.08 and 8.01 (SEC Filing) |
| 2025-01-30 | +0.1% | news | Seeking Alpha | Sanara MedTech: A Promising Growth Story At An Attractive Valuation |